Search Results - "KABEYA, K"

Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140) by NICHOLS, W. G, STEEL, H. M, BONNY, T, ADKISON, K, CURTIS, L, MILLARD, J, KABEYA, K, CLUMECK, N

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Evaluating noninvasive ventilation using a monitoring system coupled to a ventilator: a bench-to-bedside study by Rabec, C, Georges, M, Kabeya, N. K, Baudouin, N, Massin, F, Reybet-Degat, O, Camus, P

“…Empirically determined noninvasive ventilation (NIV) settings may not achieve optimal ventilatory support. Some ventilators include monitoring modules to…”
Get full text

Risk factors of osteopenia in HIV-infected women: No role of antiretroviral therapy by Libois, A, Clumeck, N, Kabeya, K, Gerard, M, De Wit, S, Poll, B, Tondeur, M, Rozenberg, Serge

“…Abstract Objectives Osteopenia and osteoporosis are more frequent in HIV-infected patients. Whether antiretroviral therapy induces a bone mineral density (BMD)…”
Get full text

Sequential treatment with 5-aza-2′deoxycitidine and deacetylase inhibitors reactivates HIV by C. Van Lint, S. Bouchat, N. Delacourt, A. Kula, G. Darcis, F. Corazza, J.S. Gatot, A. Melard, C. Vanhulle, B. Van Driessche, K. Kabeya, M. Pardons, V. Avettand-Fenoel, N. Clumeck, S. De Wit, O. Rohr, C. Rouzioux

Get full text

Experimental Study on Patient Preferences Regarding the Shape and Size of Medical Tablets and Capsules Using Three-Dimensionally Printed Plastic Model Formulations by Kabeya, Kenji, Satoh, Hiroki, Hori, Satoko, Sawada, Yasufumi

“…Tablets and capsules are the most common dosage forms. However, ease of use and/or swallowing influences patients' compliance. To identify patients'…”
Get full text

Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients by BOUCHAT, Sophie, GATOT, Jean-Stéphane, ROHR, Olivier, VAN LINT, Carine, KABEYA, Kabamba, CARDONA, Christelle, COLIN, Laurence, HERBEIN, Georges, DE WIT, Stephane, CLUMECK, Nathan, LAMBOTTE, Olivier, ROUZIOUX, Christine

“…Reactivation of HIV-1 expression in persistent reservoirs together with an efficient HAART has been proposed as an adjuvant therapy aimed at reaching a…”
Get full text

Threshold Size of Medical Tablets and Capsules: Based on Information Collected by Japanese Medical Wholesaler by Kabeya, Kenji, Satoh, Hiroki, Hori, Satoko, Miura, Yasumasa, Sawada, Yasufumi

“…Medical tablets and capsules are superior with regard to portability and are the most common dosage form in Japan. However, their large size often results in…”
Get full text

Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study by Emery, Sean, Neuhaus, Jacqueline A, Phillips, Andrew N, Babiker, Abdel, Cohen, Calvin J, Gatell, Jose M, Girard, Pierre-Marie, Grund, Birgit, Law, Matthew, Losso, Marcelo H, Palfreeman, Adrian, Wood, Robin

“…BackgroundThe SMART study randomized 5472 human immunodeficiency virus (HIV)–infected patients with CD4+ cell counts >350 cells/μL to intermittent…”
Get full text

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women by COLBERS, Angela P. H, HAWKINS, David A, TAYLOR, Graham P, MOLTO, Jose, BURGER, David M, GINGELMAIER, Andrea, KABEYA, Kabamba, ROCKSTROH, Jürgen K, WYEN, Christopher, WEIZSÄCKER, Katharina, TARIQ SADIQ, S, IVANOVIC, Jelena, GIAQUINTO, Carlo

“…To describe the pharmacokinetics of tenofovir and emtricitabine in the third trimester of pregnant HIV-infected women and at postpartum. A nonrandomized,…”
Get full text

Characteristics of "Hard-to-Use" Press-Through-Package Sheets: An Analysis of Information Collected by Marketing Specialists of a Japanese Medical Wholesaler by Kabeya, Kenji, Satoh, Hiroki, Hori, Satoko, Miura, Yasumasa, Sawada, Yasufumi

“…Press-through-package (PTP) sheets are common forms of packaging for medicines in Japan. However, patients and/or pharmacists have reported difficulty in…”
Get full text

Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine by DE WIT, S, CASSANO, P, HERMANS, P, KABEYA, K, GERARD, M, O'DOHERTY, E, CLUMECK, N

“…In conclusion, after a 9 month follow-up, viral suppression was obtained in three out of four compliant patients and immune response in five out of six…”
Get full text

Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up by Lundgren, Jens D, Babiker, Abdel, El-Sadr, Wafaa, Emery, Sean, Grund, Birgit, Neaton, James D, Neuhaus, Jacquie, Phillips, Andrew N

“…Background and methodsThe SMART study compared 2 strategies for using antiretroviral therapy—drug conservation (DC) and viral suppression (VS)—in 5472 human…”
Get full text

Ritonavir-saquinavir rescue therapy in HIV-positive patients failing with indinavir, ritonavir or saquinavir by DE WIT, S, CASSANO, P, HERMANS, P, SOMMEREIJNS, B, KABEYA, K, O'DOHERTY, E, CLUMECK, N

“…Failure in HIV-positive patients treated with triple therapy including one protease inhibitor (PI) and two reverse transcriptase inhibitors (RTI) is…”
Get full text

Healthcare delivery for HIV‐positive people with tuberculosis in Europe by Panteleev, A, Borodulina, E, Tetradov, S, Podlasin, R, Riekstina, V, Paduto, D, Mocroft, A, Trofimova, T, Miller, R, Post, F, Grezesczuk, A, Inglot, M, Podlekareva, D, Bolokadze, N, Karpov, I., Klimuk, D., Kondratenko, O., Zalutskaya, A., Bondarenko, V., Kozorez, E., Tumash, O., Kummik, T., Mshvidobadze, K., Janushkevich, I., Caplinskiene, I., Caplinskas, S., Wiercinska‐Drapalo, A., Thompson, M., Kozlowska, J., Garlicki, A., Yakovlev, A., Obel, N., Gerstoft, J., Kronborg, G., Payen, M.C., Kabeya, K., Necsoi, C., Dabis, F., Cazanave, C., Rickenbach, M., Elzi, L., Sculier, D., Cavassini, M., Bruno, A., Hoffmann, M., Vernazza, P., Fehr, J., Vora, N., Cooke, G., Wilkins, E., George, V., Mabonga, E., Waters, A., Dhar, J., Ellis, K., Galati, V., San Gerardo, A.O., Di Biagio, A., Carbonara, S., Angarano, G., Purgatorio, M., Matteelli, A., Miro, J.M., Manzardo, C., Gonzalez, J., Martinez‐Martinez, Jose A., Sanchez, F., Knobel, H., Salvadó, M., Lopez‐Colomes, J.L., Cuchí, E., Curran, A., Vidal, R., Sambeat, M.A., Pomar, V., Pozamczer, D., Saumoy, M., Moreno, A., Millet, J.P., Romero, A., Iribarren, J.A., Ibarguren, M., Moreno, S., Aldámiz‐Echevarría, T., Losso, M., Toibaro, J., Gambardella, L., Toibaro, J., Moreno Macias, L., Tavella, S., Garcia Messina, O., Laplume, H., Michaan, M., Bartoletti, B., Palmero, D., Cortes, C., Mosqueda Gomez, J.L., Villanueva, J. A., Gonzalez Hernandez, L.A., Badial, F.

“…Background In a 2013 survey, we reported distinct discrepancies in delivery of tuberculosis (TB) and HIV services in eastern Europe (EE) vs. western Europe…”
Get full text

Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy : A Randomized Trial by El-Sadr, W M, Grund, B, Neuhaus, J, Babiker, A, Cohen, C J, Darbyshire, J, Emery, S, Lundgren, J D, Phillips, A, Neaton, J D

“…Episodic use of antiretroviral therapy guided by CD4+ cell counts is inferior to continuous antiretroviral therapy. To determine whether reinitiating…”
Get full text

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study by Efsen, A.M.W., Schultze, A., Miller, R.F., Panteleev, A., Podlekareva, D.N., Miro, J.M., Girardi, E., Furrer, H., Losso, M.H., Toibaro, J., Mocroft, A., Lundgren, J.D., Post, F.A., Kirk, O., Karpov, I., Skrahina, A., Klimuk, D., Skrahin, A., Zalutskaya, A., Bondarenko, V., Mitsura, V., Tumash, O., Suetnov, O., Iljina, V., Kummik, T., Bolokadze, N., Mshvidobadze, K., Goginashvili, L., Mikiashvili, L., Bablishvili, N., Rozentale, B., Zeltina, I., Janushkevich, I., Caplinskiene, I., Caplinskas, S., Podlasin, R., Wiercinska-Drapalo, A., Thompson, M., Kozlowska, J., Bura, M., Knysz, B., Inglot, M., Garlicki, A., Duiculescu, D., Rakhmanova, A., Panteleeva, O., Kozlov, A., Vlasova, Y., Panteleev, A., Andersen, A.B., Payen, M.C., Kabeya, K., Dabis, F., Bruyand, M., Morlat, P., Ceccaldi, J., De Witte, S., Monlun, E., Lataste, P., Chossat, I., Miller, R., Vora, N., Cooke, G., Mullaney, S., Wilkins, E., George, V., Post, F., Campbell, L., Brum, R., Mabonga, E., Saigal, P., Kegg, S., Ainsworth, J., Waters, A., Dhar, J., Girardi, E., Rianda, A., Galati, V., Tommasi, C., Di Biagio, A., Carbonara, S., Purgatorio, M., Matteelli, A., Apostoli, A., Toibaro, J., Warley, E., Tavella, S., Garcia Messina, O., Laplume, H., Marson, C., Contarelia, J., Scapellato, P., Alessandro, D.D., Bartoletti, B., Palmero, D., Elias, C., Crabtree, B., Mosqueda Gomez, J.L., Villanueva, A., Gonzalez Hernandez, L.A.

“…•Management of TB/HIV co-infected patients in Eastern Europe (EE) is suboptimal.•TB/HIV co-infected patients diagnosed with MDR-TB received inferior TB…”
Get full text

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study

“…Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 cell counts have higher mortality than…”
Get full text

One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America by Podlekareva, D.N., Schultze, A., Panteleev, A., Skrahina, A.M., Miro, J.M., Rakhmanova, A., Furrer, H., Miller, R.F, Efsen, A.M.W., Losso, M.H., Toibaro, J., Vassilenko, A., Girardi, E., Lundgren, J.D., Mocroft, A., Post, F.A., Kirk, O.

“…OBJECTIVES:The high mortality among HIV/tuberculosis (TB) coinfected patients in Eastern Europe is partly explained by the high prevalence of drug-resistant…”
Get full text

Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe by Mansfeld, M, Skrahina, A, Shepherd, L, Schultze, A, Panteleev, AM, Miller, RF, Miro, JM, Zeltina, I, Tetradov, S, Furrer, H, Kirk, O, Grzeszczuk, A, Bolokadze, N, Matteelli, A, Post, FA, Lundgren, JD, Mocroft, A, Efsen, AMW, Podlekareva, DN

“…Objectives The aim of the study was to investigate the organization and delivery of HIV and tuberculosis (TB) health care and to analyse potential differences…”
Get full text

Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4 super(+) T cells from HIV-1-infected HAART-treated patients by Bouchat, S, Gatot, J-S, Kabeya, K, Cardona, C, Colin, L, Herbein, G, De Wit, S, Clumeck, N, Lambotte, O, Rouzioux, C, Rohr, O, Van Lint, C

“…Objective: Reactivation of HIV-1 expression in persistent reservoirs together with an efficient HAART has been proposed as an adjuvant therapy aimed at…”
Get full text